Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease
This study is currently recruiting participants.
Verified March 2012
by The First Affiliated Hospital of Guangzhou Medical University
Study NCT01499433 Information provided by The First Affiliated Hospital of Guangzhou Medical University
First Received on December 16, 2011. Last Updated on March 25, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Invasive Pulmonary Aspergillosis
Additional conditions recognized in this trial
Aspergillosis
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Aspergillosis
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
More general conditions related to this trial
Lung Diseases, Fungal
Mycoses
Respiratory Tract Diseases
Interventions listed in this trial
caspofungin
Additional drug interventions recognized in this trial
Echinocandins
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
The First Affiliated Hospital of Guangzhou Medical University
Merck
Back to top of Main Content